BioLineRx (BLRX) Capital Expenditures Growth (5y) (2018 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 19.74% |
| Jun 30, 2024 | -4.18% |
| Mar 31, 2024 | -0.64% |
| Dec 31, 2023 | 30.26% |
| Jun 30, 2023 | -24.95% |
| Mar 31, 2023 | 9.94% |
| Dec 31, 2022 | 24.28% |
| Sep 30, 2022 | 8.78% |
| Jun 30, 2022 | 0.45% |
| Mar 31, 2022 | 16.74% |
| Dec 31, 2021 | -20.62% |
| Jun 30, 2021 | 6.79% |
| Mar 31, 2021 | 32.64% |
| Dec 31, 2020 | 14.92% |
| Dec 31, 2019 | 15.95% |
| Sep 30, 2019 | 57.00% |
| Jun 30, 2019 | 11.71% |
| Mar 31, 2019 | 7.99% |
| Dec 31, 2018 | -26.45% |
| Jun 30, 2018 | 2.52% |
| Mar 31, 2018 | -37.47% |